Maetani S, Sugiyama T, Oku H, Shimamura I, Shimizu K, Hamada J, Moriya S
Department of Ophthalmology, Ikoma General Hospital, Japan.
Nippon Ganka Gakkai Zasshi. 1995 Jan;99(1):40-6.
We studied the effect of generally applied calcium antagonist on endothelin (ET-1) treated rabbit eyes. Nicardipine (20 micrograms/kg) was injected intravenously 15 minutes before intravitreal injection of 10 microliters of ET-1 at 10(-6) M. We measured the relative caliber of the retinal artery (the caliber of the retinal artery at the edge of the optic nerve head (ONH)/that of ONH), the capillary blood flow in ONH, visual evoked potential (VEP), intraocular pressure (IOP), and blood pressure (BP). In the control group (0.4 ml/kg of saline), administration of ET-1 caused contraction of the retinal artery, decrease of the capillary blood flow in ONH, prolongation of the VEP latency, and reduction of IOP. But these effects were significantly reduced in the calcium antagonist group. These results showed that generally applied calcium antagonist inhibits the disturbance of ocular circulation induced by ET-1. However, it also caused significant reduction of BP until 45 minutes after application, so we will have to work to find the optimum dose of calcium antagonist.
我们研究了一般应用的钙拮抗剂对经内皮素(ET-1)处理的兔眼的影响。在玻璃体内注射10微升10^(-6)M的ET-1前15分钟,静脉注射尼卡地平(20微克/千克)。我们测量了视网膜动脉的相对管径(视神经乳头边缘处视网膜动脉的管径/视神经乳头的管径)、视神经乳头处的毛细血管血流、视觉诱发电位(VEP)、眼压(IOP)和血压(BP)。在对照组(0.4毫升/千克生理盐水)中,给予ET-1会导致视网膜动脉收缩、视神经乳头处毛细血管血流减少、VEP潜伏期延长以及眼压降低。但在钙拮抗剂组中,这些效应显著降低。这些结果表明,一般应用的钙拮抗剂可抑制ET-1诱导的眼循环紊乱。然而,在应用后45分钟内它也导致血压显著降低,所以我们必须努力寻找钙拮抗剂的最佳剂量。